Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. | Nat Genet | 2012 | 5.64 |
2 | FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. | Nature | 2011 | 3.18 |